Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | ARWR | ABVX | ||
| Company | Acceleron Pharma | Arrowhead Pharma | Abivax Sa ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 78.77 | 130.61 | ||
| High | 179.85 | 78.78 | 133.50 | ||
| Low | 177.06 | 76.50 | 127.89 | ||
| Latest | 178.75 | 77.91 | 132.63 | ||
| Change | -0.93 | -1.14 | +3.13 | ||
| % Change | -0.52% | -1.44% | +2.42% | ||
| Volume | 7,884,200 | 1,441,900 | 1,886,400 | ||
| 20-Day Average Volume | 1,302,050 | 1,705,595 | 1,042,790 | ||
| Previous Close | 179.68 | 79.05 | 129.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 76.82 | 122.24 | ||
| 20-Day Raw Stochastic | 84.01% | 64.86% | 90.28% | ||
| 20-Day Relative Strength | 70.12 | 56.80 | 60.83 | ||
| Weighted Alpha | +57.78 | +263.88 | +177.82 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +3.14% since 05/21/26 | +6.93% since 05/21/26 | ||
| Low | 173.17 on 11/16/21 | 74.07 on 05/26/26 | 120.05 on 05/22/26 | ||
| High | 179.94 on 11/17/21 | 80.19 on 05/27/26 | 135.07 on 05/28/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +10.46% since 04/29/26 | +24.84% since 04/29/26 | ||
| Low | 172.25 on 10/20/21 | 69.15 on 04/30/26 | 108.12 on 04/30/26 | ||
| High | 179.94 on 11/17/21 | 82.26 on 05/14/26 | 135.07 on 05/28/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +23.14% since 02/27/26 | +9.36% since 02/27/26 | ||
| Low | 120.20 on 08/20/21 | 54.02 on 03/13/26 | 100.15 on 03/30/26 | ||
| High | 189.99 on 09/29/21 | 82.26 on 05/14/26 | 135.07 on 05/28/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +47.84% since 11/28/25 | +6.25% since 11/28/25 | ||
| Low | 113.49 on 07/15/21 | 52.23 on 12/01/25 | 100.15 on 03/30/26 | ||
| High | 189.99 on 09/29/21 | 82.26 on 05/14/26 | 148.83 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 10,974,169 | 10,569,948 | ||
| Shares Outstanding, K | 61,156 | 140,857 | 79,695 | ||
| Annual Sales | 92,520,000 | 829,450,000 | 0 | ||
| Annual Net Income | -166,030,000 | -1,630,000 | -380,270,000 | ||
| Last Quarter Sales | 34,200,000 | 73,740,000 | 0 | ||
| Last Quarter Net Income | -70,470,000 | -132,730,000 | -56,720,000 | ||
| 60-Month Beta | 0.13 | 1.28 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | -0.93 on 05/07/26 | -0.71 on 05/22/26 | ||
| Earnings Date | 02/24/22 | 08/06/26 | 09/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||